These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25157173)

  • 1. Ligand- and mutation-induced conformational selection in the CCR5 chemokine G protein-coupled receptor.
    Abrol R; Trzaskowski B; Goddard WA; Nesterov A; Olave I; Irons C
    Proc Natl Acad Sci U S A; 2014 Sep; 111(36):13040-5. PubMed ID: 25157173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric model of maraviroc binding to CC chemokine receptor 5 (CCR5).
    Garcia-Perez J; Rueda P; Alcami J; Rognan D; Arenzana-Seisdedos F; Lagane B; Kellenberger E
    J Biol Chem; 2011 Sep; 286(38):33409-21. PubMed ID: 21775441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct measurement of thermal stability of expressed CCR5 and stabilization by small molecule ligands.
    Knepp AM; Grunbeck A; Banerjee S; Sakmar TP; Huber T
    Biochemistry; 2011 Feb; 50(4):502-11. PubMed ID: 21155586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex.
    Tan Q; Zhu Y; Li J; Chen Z; Han GW; Kufareva I; Li T; Ma L; Fenalti G; Li J; Zhang W; Xie X; Yang H; Jiang H; Cherezov V; Liu H; Stevens RC; Zhao Q; Wu B
    Science; 2013 Sep; 341(6152):1387-90. PubMed ID: 24030490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of the molecular mechanism of binding kinetics and long residence times of human CCR5 receptor small molecule allosteric ligands.
    Swinney DC; Beavis P; Chuang KT; Zheng Y; Lee I; Gee P; Deval J; Rotstein DM; Dioszegi M; Ravendran P; Zhang J; Sankuratri S; Kondru R; Vauquelin G
    Br J Pharmacol; 2014 Jul; 171(14):3364-75. PubMed ID: 24628038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular interactions of CCR5 with major classes of small-molecule anti-HIV CCR5 antagonists.
    Kondru R; Zhang J; Ji C; Mirzadegan T; Rotstein D; Sankuratri S; Dioszegi M
    Mol Pharmacol; 2008 Mar; 73(3):789-800. PubMed ID: 18096812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of CC Chemokine Receptor 5 with a Potent Chemokine Antagonist Reveals Mechanisms of Chemokine Recognition and Molecular Mimicry by HIV.
    Zheng Y; Han GW; Abagyan R; Wu B; Stevens RC; Cherezov V; Kufareva I; Handel TM
    Immunity; 2017 Jun; 46(6):1005-1017.e5. PubMed ID: 28636951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural insights from binding poses of CCR2 and CCR5 with clinically important antagonists: a combined in silico study.
    Kothandan G; Gadhe CG; Cho SJ
    PLoS One; 2012; 7(3):e32864. PubMed ID: 22479344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCR5 adopts three homodimeric conformations that control cell surface delivery.
    Jin J; Momboisse F; Boncompain G; Koensgen F; Zhou Z; Cordeiro N; Arenzana-Seisdedos F; Perez F; Lagane B; Kellenberger E; Brelot A
    Sci Signal; 2018 May; 11(529):. PubMed ID: 29739880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of fusion protein FLSC IgG1 to CCR5 is enhanced by CCR5 antagonist Maraviroc.
    Latinovic O; Schneider K; Szmacinski H; Lakowicz JR; Heredia A; Redfield RR
    Antiviral Res; 2014 Dec; 112():80-90. PubMed ID: 25453341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into the mechanisms whereby low molecular weight CCR5 ligands inhibit HIV-1 infection.
    Garcia-Perez J; Rueda P; Staropoli I; Kellenberger E; Alcami J; Arenzana-Seisdedos F; Lagane B
    J Biol Chem; 2011 Feb; 286(7):4978-90. PubMed ID: 21118814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol impacts chemokine CCR5 receptor ligand-binding activity.
    Calmet P; Cullin C; Cortès S; Vang M; Caudy N; Baccouch R; Dessolin J; Maamar NT; Lecomte S; Tillier B; Alves ID
    FEBS J; 2020 Jun; 287(11):2367-2385. PubMed ID: 31738467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational ensemble view of G protein-coupled receptors and the effect of mutations and ligand binding.
    Abrol R; Kim SK; Bray JK; Trzaskowski B; Goddard WA
    Methods Enzymol; 2013; 520():31-48. PubMed ID: 23332694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A maraviroc-resistant HIV-1 with narrow cross-resistance to other CCR5 antagonists depends on both N-terminal and extracellular loop domains of drug-bound CCR5.
    Tilton JC; Wilen CB; Didigu CA; Sinha R; Harrison JE; Agrawal-Gamse C; Henning EA; Bushman FD; Martin JN; Deeks SG; Doms RW
    J Virol; 2010 Oct; 84(20):10863-76. PubMed ID: 20702642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetically encoded photo-cross-linkers map the binding site of an allosteric drug on a G protein-coupled receptor.
    Grunbeck A; Huber T; Abrol R; Trzaskowski B; Goddard WA; Sakmar TP
    ACS Chem Biol; 2012 Jun; 7(6):967-72. PubMed ID: 22455376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular binding mode of PF-232798, a clinical anti-HIV candidate, at chemokine receptor CCR5.
    Zhu Y; Zhao YL; Li J; Liu H; Zhao Q; Wu BL; Yang ZL
    Acta Pharmacol Sin; 2019 Apr; 40(4):563-568. PubMed ID: 29941870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural Analysis of Chemokine Receptor-Ligand Interactions.
    Arimont M; Sun SL; Leurs R; Smit M; de Esch IJP; de Graaf C
    J Med Chem; 2017 Jun; 60(12):4735-4779. PubMed ID: 28165741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational study on the interaction between CCR5 and HIV-1 entry inhibitor maraviroc: insight from accelerated molecular dynamics simulation and free energy calculation.
    Bai Q; Zhang Y; Li X; Chen W; Liu H; Yao X
    Phys Chem Chem Phys; 2014 Nov; 16(44):24332-8. PubMed ID: 25296959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular cysteines of CCR5 are required for chemokine binding, but dispensable for HIV-1 coreceptor activity.
    Blanpain C; Lee B; Vakili J; Doranz BJ; Govaerts C; Migeotte I; Sharron M; Dupriez V; Vassart G; Doms RW; Parmentier M
    J Biol Chem; 1999 Jul; 274(27):18902-8. PubMed ID: 10383387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cloning and radioligand binding characterization of the chemokine receptor CCR5 from rhesus macaque and human.
    Napier C; Sale H; Mosley M; Rickett G; Dorr P; Mansfield R; Holbrook M
    Biochem Pharmacol; 2005 Dec; 71(1-2):163-72. PubMed ID: 16298345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.